Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study

Fig. 3

Results by relative efficacy of preventive therapy in RISK11-positive individuals. Solid lines show median model output; shaded regions show 95% range of model outputs. Colours indicate different time horizons (see key). Left panel: ratio of cases averted (compared to universal treatment). Right panel: maximum cost of test (relative to 3HP) such that cost per case averted does not exceed cost per case averted of universal treatment

Back to article page